University of South Florida.
Michigan State University.
Oncol Nurs Forum. 2020 Nov 1;47(6):637-648. doi: 10.1188/20.ONF.637-648.
To describe patient satisfaction with an interactive voice response (IVR) system to assess adherence and symptom management in patients newly prescribed an oral anticancer agent (OAA).
SAMPLE & SETTING: Patients prescribed a new OAA were recruited from six comprehensive cancer centers in the United States.
METHODS & VARIABLES: Cross-sectional analysis and descriptive statistics were used to summarize patient demographics and satisfaction with the IVR system and symptom management toolkit.
Participants had a mean age of 61.82 years, and gastrointestinal cancer was most prevalent. Participants were either "very" or "highly" satisfied with the IVR weekly calling system to assess symptoms, the IVR system daily OAA adherence reminders, and the symptom management toolkit.
Nurses often triage patient-reported issues with OAAs. Nurses are well positioned to lead IVR system symptom management interventions and to be actively involved in the development, implementation, and dissemination of IVR technologies through research and practice.
描述患者对交互式语音应答(IVR)系统的满意度,该系统用于评估新开具口服抗癌药物(OAA)患者的依从性和症状管理情况。
在美国的六个综合性癌症中心招募了新开具 OAA 的患者。
采用横截面分析和描述性统计方法总结患者的人口统计学特征以及对 IVR 系统和症状管理工具包的满意度。
参与者的平均年龄为 61.82 岁,胃肠道癌最为常见。参与者对 IVR 每周呼叫系统评估症状、IVR 系统每日 OAA 依从性提醒以及症状管理工具包非常满意或高度满意。
护士通常会对 OAA 患者报告的问题进行分诊。护士非常适合领导 IVR 系统症状管理干预措施,并通过研究和实践积极参与 IVR 技术的开发、实施和传播。